fbpx

14th Annual Congress on Controversies in Ophthalmology

(COPHy) taking place in Lisbon, Portugal, March 24-25, 2023

Get more info

Eylea (aflibercept

Regeneron

| August 26, 2021

REGENERON ANNOUNCES ENCOURAGING TOPLINE PHASE 2 DATA OF HIGH-DOSE AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION TARRYTOWN, N.Y., Aug. 24, 2021 /PRNewswire/ — Phase 3 trials in wet AMD and diabetic macular edema…

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.